Iris disorder

Verify with FDA CVM →

VeDDRA Code: 428

86 adverse event reports referencing this reaction

86
Total Reports
18
Deaths
2090.0%
Death Rate

Species Most Affected

Dog 57
Cat 28
Horse 1

Breeds Most Affected

Domestic Shorthair 18
Dachshund (unspecified) 4
Retriever - Labrador 4
Chihuahua 3
Retriever - Golden 3
Shih Tzu 3
Boxer (German Boxer) 3
Siberian Husky 3
Shepherd Dog - Australian 2
Schnauzer - Miniature 2

Associated Drugs

Milbemycin Oxime + Spinosad 11
Enrofloxacin 6
Maropitant Citrate 6
Cefovecin 6
Cefovecin Sodium 5
Spinosad 5
Afoxolaner 5
Fluralaner Chew Tablets 5
Gabapentin 5
Robenacoxib 5
Selamectin 3
Prednisone 3
Bordetella Vaccine 3
Moxidectin 3
Recombinant Human Insulin 3
Oclacitinib Maleate 3
Cyclosporine A 3
Carprofen 3
Tramadol 3
Cyclosporine 3

Data Summary

Metric Value
Total reports referencing reaction 86
Reports with fatal outcome 18
Case-fatality rate (reported events) 2090.0%
Species observed 3
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 428.

Iris disorder Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 86 adverse event reports that reference Iris disorder as a reaction term, including 18 reports with a death outcome — a 2090.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 428, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Iris disorder appears most frequently in reports for Dog (57 reports), Cat (28 reports), Horse (1 reports) — with Dog dominating at 57 entries. Within those species, the breeds most often named alongside this reaction are Domestic Shorthair (18), Dachshund (unspecified) (4), Retriever - Labrador (4). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Iris disorder are Milbemycin Oxime + Spinosad (11 reports), Enrofloxacin (6 reports), Maropitant Citrate (6 reports), Cefovecin (6 reports), with Milbemycin Oxime + Spinosad appearing alongside this reaction in 11 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial